Recalcitrant psoriatic onycho-pachydermo-periostitis successfully treated with guselkumab

Clin Exp Dermatol. 2021 Jun;46(4):789-791. doi: 10.1111/ced.14459. Epub 2021 Feb 22.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Female
  • Humans
  • Nail Diseases / drug therapy*
  • Nail Diseases / etiology
  • Osteoarthropathy, Primary Hypertrophic / drug therapy*
  • Osteoarthropathy, Primary Hypertrophic / etiology
  • Periostitis / drug therapy*
  • Periostitis / etiology
  • Psoriasis / complications
  • Remission Induction

Substances

  • Antibodies, Monoclonal, Humanized
  • guselkumab